Page last updated: 2024-10-22

albuterol and Bone Loss, Osteoclastic

albuterol has been researched along with Bone Loss, Osteoclastic in 2 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pasaoglu, G1
Gok, H1
Mungan, D1
Sonel, B1
Yalcin, P1
Misirligil, Z1
Walker, N1
Jung, RT1
Jennings, G1
James, WP1

Trials

1 trial available for albuterol and Bone Loss, Osteoclastic

ArticleYear
Does the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up study.
    Rheumatology international, 2006, Volume: 27, Issue:2

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Albuterol; And

2006

Other Studies

1 other study available for albuterol and Bone Loss, Osteoclastic

ArticleYear
The effect of a beta-receptor agonist (salbutamol) on peripheral thyroid metabolism in euthyroid subjects.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1981, Volume: 13, Issue:10

    Topics: Adult; Albuterol; Bone Resorption; Female; Humans; Kinetics; Triiodothyronine; Triiodothyronine, Rev

1981